{{copyedit|time=2018-06-01T13:41:21+00:00}}
'''分化群'''<ref>https://www.termonline.cn/search?k=cluster%20of%20differentiation</ref>（cluster of differentiation，CD）是一用於[[细胞表面分子|细胞表面分子]]的鉴定和调查的协议（protocol）或公约，该议定提供细胞{{le|免疫表型|Immunophenotyping}}分类的靶点<ref>{{cite journal| author=CHAN, J. K. C.| author2=NG, C. S.| author3=HUI, P. K. |year=1988 |title=A simple guide to the terminology and application of leucocyte monoclonal antibodies| url=https://archive.org/details/sim_histopathology_1988-05_12_5/page/461| journal=Histopathology |volume=12 |issue=5| pages=461–480 |doi=10.1111/j.1365-2559.1988.tb01967.x | pmid=3294157 }}</ref>。由于这些靶点分子能反映细胞谱系特有分化的不同阶段，且此协议是将不同实验室的[[单克隆抗体|单克隆抗体]]所识别的同一靶点抗原，以[[流式細胞術|流式細胞術]]及[[聚类分析|聚类分析]]<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536217/pdf/bullwho00094-0127.pdf</ref><ref>https://www.sciencedirect.com/science/article/abs/pii/0165242796055675</ref>（cluster analysis，群分析）方法统整并分群<ref>https://ashpublications.org/blood/article/106/9/3123/21919/CD-molecules-2005-human-cell-differentiation</ref><ref>https://www.jimmunol.org/content/195/10/4555</ref>，因此这些靶点分子被称为'''分化群分子'''（CD分子）或'''分化群抗原'''（CD抗原）<ref>https://www.termonline.cn/word/31585/1</ref>；它们多为[[糖蛋白|糖蛋白]]分子。

在生理學上，CD分子能以多种方式发挥作用，通常作为细胞重要的[[受体_(生物化学)|受體]]或[[配體_(生物化學)|配體]]，可启动信号级联反应（瀑布式反應）进而改变细胞的行为(見 [[细胞信号传送|cell signaling]])。有些CD蛋白則與細胞傳訊無關，但有著其他功能，如{{tsl|en|cell adhesion||細胞黏附}}、细胞激活或细胞抑制。 <!--There are approximately 250 different proteins.-->人類的CD分子總數為371({{As of|2016|04|21|lc=y}}).<ref name=hcdm>{{cite web | title=HCDM, responsible for HLDA workshop and CD molecules | url=http://www.hcdm.org/MoleculeInformation/tabid/54/Default.aspx | work= | publisher=Human Cell Differentiation Molecules Council (successor to the HLDA Workshops) | date= | accessdate=2016-04-21 | archive-date=2016-04-20 | archive-url=https://web.archive.org/web/20160420020358/http://www.hcdm.org/MoleculeInformation/tabid/54/Default.aspx | dead-url=yes }}</ref><ref name="pmid16020511">{{cite journal | vauthors = Zola H, Swart B, Banham A, Barry S, Beare A, Bensussan A, Boumsell L, D Buckley C, Bühring HJ, Clark G, Engel P, Fox D, Jin BQ, Macardle PJ, Malavasi F, Mason D, Stockinger H, Yang X | title = CD molecules 2006--human cell differentiation molecules. | journal = J Immunol Methods. | volume =  319| issue = 1–2 | pages = 1–5 | year = 2007 | pmid = 17174972 | doi = 10.1016/j.jim.2006.11.001 }}</ref>

== 命名 ==
'''分化群命名法'''（CD nomenclature）是1982年在[[巴黎|巴黎]]舉辦的第一屆人類[[白血球|白血球]]分化[[抗原|抗原]]國際工作坊與討論會（HLDA）所決定的<ref name="pmid6239187">{{cite journal | vauthors = Bernard A, Boumsell L | title = [Human leukocyte differentiation antigens] | language = fr | journal = Presse Med | volume = 13 | issue = 38 | pages = 2311–6 | year = 1984 | pmid = 6239187 | doi =  }}</ref><ref name="pmid6240938">{{cite journal | vauthors = Fiebig H, Behn I, Gruhn R, Typlt H, Kupper H, Ambrosius H | title = Charakterisierung einer Serie von monoklonalen Antikörpern gegen humane T-Zellen |trans-title=Characterization of a series of monoclonal antibodies against human T cells | language = de | journal = Allerg Immunol (Leipz) | volume = 30 | issue = 4 | pages = 242–50 | year = 1984 | pmid = 6240938 | doi = }}</ref>。此系統當時之目的，是為了分類各地實驗室針對“白血球表面分子的[[表位|表位]]”所製作的[[单克隆抗体|单克隆抗体]]（mAbs）。自那時起，這項分類法的用途也擴展到不同細胞類型的領域，而且已有超過370個獨特的分化群及亞群被鑑定出來。当有两种特定的单抗被证明可与某大会提名的表面分子结合，工作坊就指派一个CD编号给该分子；但若該大會提名分子尚無法明確描述其特徵，或只有一單抗能與之結合，就赋予其暂定指标"w" （如"CDw186"）。

举例来说，“CD2单抗”是与T细胞上表达的一种50-kDa跨膜糖蛋白反应的试剂；后来，由于CD命名被用来描述被识别出的分子而非原来的单抗，此命名就必须在名称中附加抗原或分子一词加以澄清（如“CD2分子”）。现今，一般用“CD2”来表示此表面分子，用“CD2抗体”来表示其单抗。

一般使用"+"或"-"符号来表示细胞群中是否有某些细胞表达或缺乏某种CD分子，如"[[CD34|CD34]]+, {{tsl|en|CD31|CD31}}-"細胞是會表現CD34，但不會表現CD31的細胞；這種CD組合通常就是[[幹細胞|幹細胞]]而非完全分化的[[內皮|上皮細胞]]。有些細胞群則會以 <sup>hi</sup>，<sup>mid</sup> 或 <sup>low</sup>（另可用 <sup>bright</sup>，<sup>mid</sup> 或 <sup>dim</sup>）来标示CD分子表达的总体变异性，特别是与其他正在研究的细胞群相比的时候。例如研究T细胞在胸腺内的发育时，就会使用这种标示来分辨由CD4<sup>mid</sup>/CD8<sup>mid</sup>细胞转变来的CD4<sup>hi</sup>/CD8<sup>mid</sup>细胞。<ref name="pmid19151747">{{cite journal | vauthors = Ho IC, Tai TS, Pai SY | title = GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation | journal = Nature Reviews Immunology | volume = 9 | issue = 2 | pages = 125–35 |date=February 2009 | pmid = 19151747 | pmc = 2998182 | doi = 10.1038/nri2476 }}</ref>

== 人類白血球抗原分化工作坊==
自1982年以來從開始到結束共有9次會議

{| class="wikitable"
|-
! 工作坊 !! 城市 !! 年份 !! CDs assigned !! 參考資料
|-
| I || [[巴黎|Paris]] || 1982 || 1-15 || <ref>{{cite book|last1=Bernard|display-authors=etal|first1=AR|title=Leucocyte Typing: Human Leucocyte Differentiation Antigens Detected by Monoclonal antibodies|date=1984|publisher=Berlin: Springer-Verlag}}</ref>
|-
| II || [[波士顿|Boston]] || 1984 || 16-26 || <ref>{{cite book|last1=Reinherz|display-authors=etal|first1=EL|title=Leukocyte Typing II|date=1985|publisher=New York: Springer-Verlag}}</ref>
|-
| III || [[牛津|Oxford]] || 1986 || 27-45 || <ref>{{cite book|last1=McMichael|display-authors=etal|first1=AJ|title=Leucocyte Typing III. White Cell Differentiation Antigens.|date=1987|publisher=Oxford University Press}}</ref>
|-
| IV || [[維也納|Vienna]] || 1989 || 46-78 || <ref>{{cite book|last1=Knapp|display-authors=etal|first1=W|title=Leucocyte Typing IV|date=1989|publisher=Oxford University Press}}</ref>
|-
| V || [[波士顿|Boston]] || 1993 || 79-130 || <ref>{{cite book|last1=Schlossman|display-authors=etal|first1=SF|title=Leucocyte Typing V: White cell differentiation antigens|date=1995|publisher=Oxford University Press}}</ref>
|-
| VI || [[神户市|Kobe]] || 1996 || 131-166 || <ref>{{cite book|last1=Kishimoto|display-authors=etal|first1=T|title=Leucocyte Typing VI|date=1997|publisher=Garland Publishing}}</ref>
|-
| VII || [[哈罗盖特|Harrogate]] || 2000 || 167-247 || <ref>{{cite book|last1=Mason|display-authors=etal|first1=D.|title=Leucocyte Typing VII|date=2002|publisher=Oxford University Press}}</ref>
|-
| VIII || [[阿德莱德|Adelaide]] || 2004 || 248-339 || <ref>{{cite journal
 |vauthors=Zola H, Swart B, Nicholson I, Aasted B, Bensussan A, Boumsell L, Buckley C, Clark G, Drbal K, Engel P, Hart D, Horejsí V, Isacke C, Macardle P, Malavasi F, Mason D, Olive D, Saalmueller A, Schlossman SF, Schwartz-Albiez R, Simmons P, Tedder TF, Uguccioni M, Warren H
 |title=CD molecules 2005: human cell differentiation molecules
 |url=https://archive.org/details/sim_blood_2005-11-01_106_9/page/3123
 |journal=Blood.
 |volume=106
 |issue=9
 |pages=3123–6
 |date=November 1, 2005
 |doi= 10.1182/blood-2005-03-1338
 |pmid=16020511
}}</ref>
|-
| IX || [[巴塞罗那|Barcelona]] || 2010 || 340-364 || <ref>{{cite journal|title=Proceedings of the 9th International Workshop on Human Leukocyte Differentiation Antigens. March 2010. Barcelona, Spain.|journal=Immunol Lett.|date=30 January 2011|volume=134|issue=2|pages=103–187}}</ref>
|-
| X || [[卧龙岗_(新南威尔士州)|Wollongong]] || 2014 || 365-371 ||
|}

==免疫抗原辨識==
[[File:Cluster_of_differentiation.svg|thumb]]
CD系統通常用作免疫抗原辨識的細胞標記，我們可藉此技術觀察細胞表面的分子並辨識該細胞。 這些標記通常與該細胞特定的免疫功能有關。單單僅以CD分子區分某特定細胞的情況很少見，但藉由與細胞標記一同使用，可以讓我們能精確區分各種存在於免疫系統中的細胞。

CD也被用於[[流式細胞術|流式細胞術]]中

{| class="wikitable"
| '''Type of cell''' || '''CD markers'''
 |-
 | [[幹細胞|幹細胞]]s || [[CD34|CD34]]+, {{tsl|en|CD31||CD31}}-, {{tsl|en|CD117||CD117}}
 |-
 | all [[白血球|白血球]] groups || {{tsl|en|CD45||CD45}}+
 |-
 | [[粒细胞|粒细胞]]  || CD45+, {{tsl|en|CD11b||CD11b}}, {{tsl|en|CD15||CD15}}+, [[CD24|CD24]]+, {{tsl|en|CD114||CD114}}+, CD182+<ref name="docs.abcam.com">{{cite web|url=http://docs.abcam.com/pdf/immunology/cdantigen_poster.pdf|format=PDF|title=CD Antigens|publisher=abcam|year=2009|accessdate=2014-11-22|archive-date=2018-07-12|archive-url=https://web.archive.org/web/20180712220007/http://docs.abcam.com/pdf/immunology/cdantigen_poster.pdf|dead-url=no}}</ref>
 |-
 | [[单核细胞單核細胞|单核细胞單核細胞]] || CD4, CD45+, {{tsl|en|CD14||CD14}}+, {{tsl|en|CD114||CD114}}+,  {{tsl|en|CD11a||CD11a}}, CD11b, CD91+,<ref name="docs.abcam.com"/> [[CD16|CD16]]+<ref>{{cite journal | vauthors=Passlick B, Flieger D, Ziegler-Heitbrock HW | title=Identification and characterization of a novel monocyte subpopulation in human peripheral blood | journal={{tsl|en|Blood (journal)||Blood}} | volume=74 | issue=7 | year=1989 | pages=2527–2534 | url=http://bloodjournal.hematologylibrary.org/content/74/7/2527.long | pmid=2478233 | author= | access-date=2018-05-25 | archive-url=https://web.archive.org/web/20130619015706/http://bloodjournal.hematologylibrary.org/content/74/7/2527.long | archive-date=2013-06-19 | dead-url=yes }}</ref>
 |-
 | [[T细胞|T 細胞]] || CD45+, {{tsl|en|CD3 (immunology)||CD3}}+
 |-
 | [[輔助型T細胞|輔助型T細胞]] || CD45+, CD3+, [[CD4受体|CD4]]+
 |-
 | [[调节T细胞|调节T细胞]] ||[[CD4受体|CD4]], {{tsl|en|CD25||CD25}}, {{tsl|en|FOXP3||FOXP3 (a transcription factor)}}
 |-
 | [[细胞毒性T细胞|细胞毒性T细胞]] || CD45+, CD3+, [[CD8受体|CD8]]+
 |-
 | [[B细胞|B细胞]] || CD45+, {{tsl|en|CD19||CD19}}+, {{tsl|en|CD20||CD20}}+, [[CD24|CD24]]+, {{tsl|en|CD38||CD38}}, [[CD22|CD22]]
 |-
 | [[血小板|血小板]] || CD45+, [[CD61|CD61]]+
 |-
 | [[自然杀伤细胞|自然杀伤细胞]] || [[CD16|CD16]]+, [[神經元黏附分子|CD56]]+, CD3-, {{tsl|en|CD31||CD31}}, {{tsl|en|CD30||CD30}}, CD38
|}

最常使用的CD分子是[[CD4受体|CD4]]與[[CD8受体|CD8]]，通常分別用作[[輔助型T細胞|helper]]和[[细胞毒性T细胞|cytotoxic]]的標記。這些分子會與CD3+一同作為區分的條件，而某些白血球也會表現這些CD分子(一些巨噬細胞會表現區低程度的CD4， [[樹狀細胞|樹狀細胞]]會表現高程度的CD8)愛滋病毒會與CD4及一種位於輔助T細胞表面的趨化因子受體作結合並藉此進入細胞內。而CD4與CD8的血液濃度也經常用作愛滋感染的檢驗標準。

==生理學上的功用==
雖然CD分子在區分白血球上成效不斐，但其功能並不僅止於此。雖然目前僅有部分CD分子被徹底分析，但CD分子大多具重要功能。如CD4與CD8在 [[抗原|抗原]]辨識中扮演關鍵角色一樣，其餘如CD135作為細胞表面的成長因子受體有著重要功能。

==參考資料==
{{Reflist|2}}

==參見==
{{div col|2}}
*[[免疫系统|免疫系统]]
*[[免疫耐受|免疫耐受]]
*[[抗体|抗体]]
*[[白血球|白血球]]
*{{tsl|en|List of human clusters of differentiation||List of human clusters of differentiation}}
*[[主要组织相容性复合体|主要组织相容性复合体]]
*[[訊息傳遞_(生物)|訊息傳遞]]
*腎臟疾病的{{tsl|en|CD13||CD13}} 標記
* [[急性骨髓性白血病|AML]] 治療中的[[CD33|CD33]] 標記
*[[CTLA-4|CTLA-4]](CD152)
*[[程序性細胞死亡的蛋白質1|程序性細胞死亡的蛋白質1]](Programmed cell death protein 1；PD1；CD279)
{{div col end}}

==外部链接==
* [http://www.hcdm.org/MoleculeInformation/tabid/54/Default.aspx Molecule search]{{Wayback|url=http://www.hcdm.org/MoleculeInformation/tabid/54/Default.aspx |date=20160420020358 }} maintained by the Human Cell Differentiation Molecules Council (successor to the HLDA Workshops)
<!-- This should probably remain at the top of the list -->
* [http://www.immunologylink.com/cdantigen.html Table of CD Antigens]{{Wayback|url=http://www.immunologylink.com/cdantigen.html |date=20101208190301 }}
* [http://www.sciencegateway.org/resources/prow/index.html CD list] {{Wayback|url=http://www.sciencegateway.org/resources/prow/index.html |date=20161207034249 }} Protein Reviews On The Web
* Yet another [http://pathologyoutlines.com/cdmarkers.html list of CD molecules] {{Wayback|url=http://pathologyoutlines.com/cdmarkers.html |date=20201215133246 }}, at PathologyOutlines.com
* [http://www.ebioscience.com/ebioscience/litreq.asp Wall charts]{{Wayback|url=http://www.ebioscience.com/ebioscience/litreq.asp |date=20070409083629 }} of CD molecules and other cytokines, with colors, arrows from one cell to another, from eBioscience.
* [http://umr976.simdif.com// Skin Research Center lab] {{Wayback|url=http://umr976.simdif.com// |date=20181114011309 }} Hopital St Louis, Paris (France) Dir. Dr. A. Bensussan

{{Clusters of differentiation}}
{{Surface antigens}}
{{Portal bar|Molecular and cellular biology}}

[[Category:病理解剖學|Category:病理解剖學]]
[[Category:分化群|*]]
[[Category:Antigens|Category:Antigens]]